Rare Disease Prioritization Model and Landscape Analysis
A pharmaceutical company sought an objective assessment of multiple rare diseases to identify the most promising indications in which to develop preclinical candidate molecules. Citeline created a weighted prioritization model to assess each rare disease.
薬事規制関連支援サービス
AstraZeneca Takes an Innovative Approach to Trial Results Summaries
AstraZeneca made a commitment to deliver plain language summaries (PLS) in advance of the European Medicines Agency (EMA) policy. Partnering with Citeline, AstraZeneca decided its results would be available on TrialSummaries.com.
研究開発支援サービス
Citeline Connect Key to Record-setting Clinical Trial Recruitment
Within just days, Citeline Connect mobilized 20 recruitment partners to begin referring patients for a COVID-19 vaccine trial.